BioPorto Announces NIH-Funded Study to Explore the Ability of Renal Biomarkers in Predicting Severe AKI, Advancing Beyond NLP-based AI Algorithms
Morning Star,
July 30, 2024 News Release ADLM 2024 Conference – Chicago, July 30, 2024 – BioPorto Diagnostics, a pioneering company in the…